PHILADELPHIA, Nov. 12, 2010 /PRNewswire-FirstCall/ -- ERT
(Nasdaq: ERES), announced today that Dr. Michael J. McKelvey,
the Company's President and CEO, is scheduled to present at Lazard
Capital Markets' 7th Annual Healthcare Conference at 10:55 AM EST on November 16, 2010 in
New York City, New York.
Interested parties may access the presentation by visiting the
Company's corporate website at http://www.ert.com. The webcast
may also be accessed at http://www.wsw.com/webcast/lz8/eres/.
The webcast will be available via replay for 90 days.
About ERT
Based in Philadelphia, PA,
eResearchTechnology, Inc. (www.ert.com) is a global provider of
technology and services to the pharmaceutical, biotechnology and
medical device industries. The Company is a market leader in
providing centralized core-diagnostic electrocardiographic (ECG)
technology and services to evaluate cardiac safety in clinical
development. It is also a leading provider of centralized
respiratory technology and services to evaluate pulmonary function
efficacy and safety in clinical development. Sponsors can
further use the Company's solutions to streamline the clinical
trials process by automating the collection, analysis, and
distribution of ePRO clinical data using multi-mode technology in
all phases of clinical development as well as selected medical
devices for the clinical trials and healthcare industries.
Statements included in this release may constitute
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such statements involve a
number of risks and uncertainties, which could cause actual results
to differ materially from those expressed or implied from such
statements. These risks and uncertainties include, without
limitation, the Company's ability to obtain new contracts,
variability in size, scope, and duration of projects, integration
of acquisitions, competitive factors, technological development,
market demand, and other factors described in the Company's filings
with the Securities and Exchange Commission. The Company
undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events,
or otherwise.
SOURCE ERT